Literature DB >> 21099567

Management of the great mimicker: Meckel cave tumors.

Rashid M Janjua1, Kondi M Wong, Akash Parekh, Harry R van Loveren.   

Abstract

BACKGROUND: Meckel cave tumors are often asymptomatic and have a sufficiently characteristic magnetic resonance imaging/computed tomography signature that allows treatment/surveillance decisions to be made without biopsy confirmation. Radiographic diagnosis requires the surgeon to be fully aware of the plethora of unusual Meckel cave lesions that mimic benign tumors when they are malignant, inflammatory, or infectious and in need of a completely different and often timely intervention. When such a diagnosis is considered, it behooves the surgeon and benefits the patient to have a percutaneous biopsy technique available.
OBJECTIVE: To use our recent experience with a patient with idiopathic inflammatory sensory neuropathy and another with Meckel cave lymphoma to review the management of tumors of the Meckel cave.
METHODS: The technique of percutaneous biopsy of Meckel cave tumors through the foramen ovale with biopsy needles is detailed.
CONCLUSION: Obtaining tissue biopsy percutaneously prevents patients with Meckel cave tumors best treated with nonsurgical management from undergoing open surgical resection with its concomitant morbidity.

Entities:  

Mesh:

Year:  2010        PMID: 21099567     DOI: 10.1227/NEU.0b013e3181fa265d

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  2 in total

1.  Multimodality Management of Trigeminal Schwannomas.

Authors:  Ajay Niranjan; Samuel Barnett; Vijay Anand; Siviero Agazzi
Journal:  J Neurol Surg B Skull Base       Date:  2016-04-22

2.  A rare case of Meckel's cave primary lymphoma: a case report and elaboration of the diagnostic algorithm.

Authors:  Francesco Paglia; Valerio di Norcia; Luca D'Angelo; Luigi Valentino Berra; Antonio Santoro
Journal:  Acta Neurol Belg       Date:  2020-01-25       Impact factor: 2.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.